Jadelle®: Progesterone-only implant contraception

To enable women requesting contraception to make informed choices about managing their fertility.

Jadelle® is a long-acting reversible contraceptive (LARC), consisting of two levonorgestrel-releasing subdermal rods approved by the FDA in 1996 (though not marketed in the U.S.). It provides up to 5 years of effective contraception and is approved for use in many countries worldwide. Levonorgestrel implant devices, including Jadelle, are used by millions of women globally.

By the end of the course you will be able to:

• Advise women and men requesting contraception and enable them to make informed choices about managing their fertility.
• Appropriately consult with and assess women who wish to use the Jadelle implant.
• Understand the composition and pharmacokinetics of the Jadelle^® implant and potential drug interactions.
• Explain the indications and contraindications, medical eligibility criteria, advantages and disadvantages, side effects and complications of Jadelle^® implant use.
• Understand the mode of action and contraceptive efficacy of implants.
• Manage side effects of Jadelle, including bleeding problems.
• Describe the management of an impalpable implant.

Acknowledgements

This content was created by Dr Orna McGinn, MRCGP (UK) DRCOG DFFP FRCNZGP. It was reviewed by Katie McCullough, Nurse Practitioner - Mātanga Tapuhi, MNSc (hons).